Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Regadenoson

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 4,548,904Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Indies Pharma`s Generics Regadenoson Receives Approval in US
    Indies Pharma`s Generics Regadenoson Receives Approval in US

    22 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218054

    FDA
    22 Aug 2024
    Share Share
    GE Healthcare's Generics Regadenoson Receives Approval in US
    GE Healthcare's Generics Regadenoson Receives Approval in US

    05 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215955

    FDA
    05 Aug 2024
    Share Share
    Baxter's Generic Regadenoson Monohydrate Receives Receives Approval in the U.S.
    Baxter's Generic Regadenoson Monohydrate Receives Receives Approval in the U.S.

    23 May 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217455

    FDA
    23 May 2023
    Share Share
    Astellas Confirms Final Federal Circuit Decision in LEXISCAN Patent Appeal
    Astellas Confirms Final Federal Circuit Decision in LEXISCAN Patent Appeal

    12 May 2023

    // PRESS RELEASE

    https://www.astellas.com/en/news/27761

    PRESS RELEASE
    12 May 2023
    Share Share
    Dr Reddy's Laboratories launches Regadenoson injection in US market
    Dr Reddy's Laboratories launches Regadenoson injection in US market

    05 May 2023

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-laboratories-launches-regadenoson-injection-in-us-market/articleshow/100014221.cms

    ECONOMICTIMES
    05 May 2023
    Share Share
    Mylan's Generic Regadenoson MonohydrateReceives Approval in the U.S.
    Mylan's Generic Regadenoson MonohydrateReceives Approval in the U.S.

    04 Apr 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213856

    FDA
    04 Apr 2023
    Share Share